Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial (Q82779804)
Jump to navigation
Jump to search
scientific article published on 01 March 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial |
scientific article published on 01 March 2006 |
Statements
Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial (English)
Charles N Bernstein
Stefan Schreiber
Brian Feagan
Jean-Frederic Colombel
Karel Geboes
Mikhail Yurcov
Oleg Golovenko
Diether Ludwig
Trevor Winter
Ulrich Meier
Chan Yong
Jürgen Steffgen
BIRB 796 Study Group